Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126027493 | 12602749 | 3 | F | 20160817 | 20160728 | 20160824 | EXP | BR-PFIZER INC-2016326813 | PFIZER | 53.00 | YR | F | Y | 0.00000 | 20160824 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126027493 | 12602749 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | UNK | 20597 | EYE DROPS, SOLUTION | |||||||||
| 126027493 | 12602749 | 2 | SS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 DROP ON EACH EYE ONCE A DAY | M00717 | 20597 | 2 | GTT | EYE DROPS, SOLUTION | QD | |||||
| 126027493 | 12602749 | 3 | SS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 DROP ON EACH EYE ONCE A DAY | 20597 | 2 | GTT | EYE DROPS, SOLUTION | QD | ||||||
| 126027493 | 12602749 | 4 | SS | ALPHAGAN P | BRIMONIDINE TARTRATE | 1 | Ophthalmic | ONE DROP ON EACH EYE TWICE A DAY | 0 | 2 | GTT | BID | |||||||
| 126027493 | 12602749 | 5 | C | LACRIMA PLUS | DEXTRAN 70HYPROMELLOSES | 1 | Ophthalmic | FOUR TIMES A DAY, ONE DROP ON EACH EYE | 0 | 2 | GTT | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126027493 | 12602749 | 1 | Glaucoma |
| 126027493 | 12602749 | 4 | Glaucoma |
| 126027493 | 12602749 | 5 | Glaucoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126027493 | 12602749 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126027493 | 12602749 | Drug hypersensitivity | |
| 126027493 | 12602749 | Drug ineffective | |
| 126027493 | 12602749 | Ocular discomfort | |
| 126027493 | 12602749 | Ocular hyperaemia | |
| 126027493 | 12602749 | Vision blurred | |
| 126027493 | 12602749 | Visual field defect |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126027493 | 12602749 | 1 | 201403 | 201410 | 0 | |
| 126027493 | 12602749 | 2 | 201510 | 0 | ||
| 126027493 | 12602749 | 3 | 20160428 | 0 |